PRESS RELEASE published on 09/13/2025 at 01:00, 7 months 26 days ago BioNxt Announces Shares for Debt Settlement BioNxt Solutions Inc. announces a debt settlement agreement with a creditor, issuing common shares and making a cash payment. Company focuses on bioscience innovations and drug delivery technologies Innovation Debt Settlement BioScience Drug Delivery BioNxt
BRIEF published on 09/05/2025 at 09:10, 8 months 3 days ago BioNxt Solutions fait ses débuts sur le marché OTCQB Divulgation Financière Marché OTCQB Développement De Médicaments Investisseurs Américains Solutions BioNxt
BRIEF published on 09/05/2025 at 09:10, 8 months 3 days ago BioNxt Solutions Debuts on OTCQB Market Financial Disclosure Drug Development US Investors BioNxt Solutions OTCQB Market
PRESS RELEASE published on 09/05/2025 at 09:05, 8 months 3 days ago BioNxt Solutions Completes Up-Listing to The OTCQB Market BioNxt Solutions Inc. announces up-listing to OTCQB market, expanding access to US investors. Three drug development programs underway in Europe & North America. Company focuses on innovative drug delivery platforms Drug Development BioNxt Solutions Inc. US Investors OTCQB Market Innovative Drug Delivery
BRIEF published on 09/02/2025 at 09:10, 8 months 6 days ago BioNxt commence le développement à l'échelle du laboratoire d'un film oral à base de sémaglutide Solutions BioNxt Administration De Médicaments Semaglutide ODF Formulation À L'échelle Du Laboratoire Développement De Brevets
BRIEF published on 09/02/2025 at 09:10, 8 months 6 days ago BioNxt Begins Lab-Scale Development of Semaglutide Oral Film Drug Delivery BioNxt Solutions Semaglutide ODF Lab-scale Formulation Patent Development
PRESS RELEASE published on 09/02/2025 at 09:05, 8 months 6 days ago Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt BioNxt Solutions announces receipt of Semaglutide API for laboratory-scale testing of ODF delivery system. Collaboration with Gen Plus for European drug development hub BioNxt Solutions Semaglutide API ODF Delivery System Laboratory-scale Testing Gen Plus
BRIEF published on 08/23/2025 at 02:10, 8 months 17 days ago BioNxt Solutions Engages in Investor Relations Initiatives Brand Visibility Investor Relations BioNxt Solutions Apaton Finance Cayo Ventures
BRIEF published on 08/23/2025 at 02:10, 8 months 17 days ago BioNxt Solutions s'engage dans des initiatives de relations avec les investisseurs Relations Avec Les Investisseurs Visibilité De La Marque Solutions BioNxt Apaton Finance Cayo Ventures
PRESS RELEASE published on 08/23/2025 at 02:05, 8 months 17 days ago Promotional Activity Engagements BioNxt Solutions Inc. engages Apaton Finance GmbH and Cayo Ventures GmbH for investor relations services. Apaton to enhance brand visibility, Cayo for digital marketing to drive website traffic Digital Marketing Investor Relations BioNxt Solutions Inc. Apaton Finance GmbH Cayo Ventures GmbH
Published on 05/09/2026 at 01:30, 44 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 hours 14 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 5 hours 36 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 7 hours 1 minute ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 7 hours 12 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 7 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 7 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 7 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
